Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade
These are Goldman Sachs' favorite stocks with 50% or more upside
Quanterix First Quarter 2024 Earnings: Beats Expectations
Outperform Rating and $30 Price Target for Quanterix Amid Strong Position in Alzheimer’s Diagnostics Market
Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript
Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Advances in Biomarker Technology
Q1 2024 Quanterix Corp Earnings Call Transcript
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Quanterix Releases Financial Results for the First Quarter of 2024
Quanterix To Report First Quarter 2024 Financial Results
Quanterix To Report First Quarter 2024 Financial Results
Quanterix To Report First Quarter 2024 Financial Results
Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX)
Quanterix’s Strong IP Position Fuels Buy Rating in Alzheimer’s Diagnostic Market
TD Cowen Sticks to Their Hold Rating for Quanterix (QTRX)
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
Quanterix’s Growth Catalysts: FDA Breakthrough Designation and Alzheimer’s Diagnostic Potential
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.